Paralytic ileus is marked by the cessation of bowel motility. This condition is a major clinical concern that may lead to severe patient morbidity in orthopaedic surgery and trauma patients. Ileus most commonly occurs following spinal surgery, traumatic injury, or lower extremity joint reconstruction, but it may also occur following minor orthopaedic procedures. Possible consequences of ileus include abdominal pain, malnutrition, prolonged hospital stay, hospital readmission, bowel perforation, and death. Therapies used in the treatment of ileus include minimization of opioids, early patient mobilization, pharmacologic intervention, and multidisciplinary care. Orthopaedic surgeons should be aware of the clinical signs and symptoms of paralytic ileus and should understand treatment principles of this relatively common adverse event.
P aralytic ileus is defined as a temporary cessation of propulsive contractions of the gastrointestinal tract, with subsequent gut dilation and accumulation of secretions and gas within its lumen. 1 It is a relatively common postoperative complication following major orthopaedic surgery, occurring in 0.3% to 8.4% of patients depending on the invasiveness and anatomic location of the surgery. 2, 3 Ileus commonly presents with abdominal distention and discomfort, bloating, belching, nausea, emesis, and constipation. This complication may lead to substantial morbidity and may be fatal in severe cases. [3] [4] [5] [6] [7] [8] [9] [10] Although ileus occurs in approximately 15% of patients after abdominal surgical procedures, 1 ileus may also occur in orthopaedic surgery patients who have not been subjected to violation of the peritoneal cavity during their procedures. In these cases, the causative etiology is likely multifactorial, including neurogenic, inflammatory, hormonal, and pharmacologic factors. 11 In the orthopaedic population, ileus is most commonly encountered following spine surgery, lower extremity reconstruction, and traumatic injuries with or without intra-abdominal injury. Although much of the available literature surrounding ileus is devoted to patients undergoing intraabdominal procedures, pain, immobility, and autonomic dysfunction are shared elements in many surgical patients and are relevant factors following orthopaedic surgery.
Ileus is defined as either uncomplicated or complicated. 12 Uncomplicated ileus lasts #3 days and is self-limiting. Complicated ileus is associated with prolonged cessation of gastrointestinal motility and lasts .3 days. Typical symptoms include abdominal distention, bloating, nausea, emesis, pain, and constipation. 13 An important variant of ileus is Ogilvie syndrome, also known as acute colonic pseudo-obstruction; this syndrome is well described in the orthopaedic literature. 14 syndrome tends to affect certain populations, such as elderly nursing home residents admitted for a hip fracture; these patients may have a baseline of chronic constipation and take a variety of psychiatric medications for dementia and behavior control. These medications have inhibitory effects on gastrointestinal motility, and when combined with anesthesia effects and narcotic administration, Ogilvie syndrome may arise. This functional, rather than mechanical, obstruction, consisting of massive dilation of the cecum and the ascending colon, is the result of autonomic dysfunction and the inhibition of parasympathetic activity on colonic motor function. If left untreated, toxic megacolon may occur. Progressive cecal dilation causes compression of vessels in the colon wall, leading to ischemia and bowel wall thinning. Colonic perforation, intra-abdominal sepsis, and death may ensue. 13 
Ileus in the Orthopaedic Surgery Patient
Ileus following elective spine surgery is a relatively common adverse event, occurring in approximately 3.5% of patients undergoing lumbar spine surgery. 2, 4, 18, 19 Spine surgery is unique among orthopaedic procedures because the anterior approach around the peritoneal cavity and into the retroperitoneal space is commonly performed. A retrospective study that evaluated .200,000 patients showed an overall ileus incidence depending on the type of surgical approach taken; patients undergoing a posterior lumbar spinal fusion had an ileus rate of 2.6% compared with a rate of 7.5% for patients undergoing anterior lumbar spinal fusion. 2 For patients who had both anterior and posterior approaches, the incidence of ileus was 8.4%. Not surprisingly, patients who had ileus had a significantly longer length of stay (ie, approximately 2.5 days longer), as well as greater hospital costs (approximately $7,000 higher) than did patients without ileus.
A retrospective review of patients undergoing lateral lumbar spine surgery reported the incidence of ileus at 7%. 4 Independent risk factors cited in this study included a history of gastroesophageal reflux disease and posterior instrumentation. 4 A review of patients with ankylosing spondylitis undergoing spinal osteotomy revealed a lower rate of paralytic ileus in patients undergoing closing wedge osteotomy compared with patients undergoing opening wedge osteotomy. 19 Other complications, such as superior mesenteric artery syndrome and celiac artery compression, although much less common than ileus, have been reported following spinal deformity surgery, 20, 21 and should be considered in the differential diagnosis when postoperative nausea and vomiting are encountered. Ogilvie syndrome has also been reported after lumbar and cervical surgery, as well as after correction of spinal deformity. 17 The rate of ileus following lower extremity arthroplasty has been reported between 0.3% and 4% after primary arthroplasty, and up to 5.6% after revision surgery. 3 Patients confined in bed secondary to ileus are at a greater risk for venous thromboembolic disease after total joint arthroplasty. 6 Excessive anticoagulation with warfarin and an international normalized ratio .2.0 may also be independent risk factors for the development of ileus after joint arthroplasty surgery. 22 Ogilvie syndrome has been reported in patients undergoing lower extremity reconstruction, most commonly occurring after total hip arthroplasty. A retrospective study by Norwood et al 23 found the rate of Ogilvie syndrome to be 1.3% in patients undergoing total hip arthroplasty and 0.6% in patients undergoing total knee arthroplasty. Patients diagnosed with Ogilvie syndrome stayed in the hospital approximately 8 days longer than patients without a diagnosis of Ogilvie syndrome; all patients in this study responded to nonsurgical management.
Ileus is also known to occur in orthopaedic trauma patients, regardless whether they sustain abdominal trauma or undergo surgical procedures. Polytrauma patients with intra-abdominal injuries who have undergone an exploratory laparotomy, with or without a bowel resection, are at a high risk for ileus because of bowel manipulation and postoperative narcotic use. In particular, patients with flexion-distraction thoracolumbar spinal injuries are at risk of ileus because of concurrent spino-abdominal trauma. Similarly, orthopaedic trauma patients with spinal injuries and pelvic or long bone fractures that require surgery are at risk for the development of ileus because of narcotic pain medication, immobility, and autonomic dysfunction in the perioperative period.
Although much less common than ileus, and clinically distinct from it, bowel entrapment within a pelvic fracture has been reported and is a potentially fatal complication. This occult injury typically presents as a prolonged or intermittent ileus following a pelvic fracture. 24 Prompt recognition and surgical intervention are important because considerable morbidity is associated with a delay in diagnosis.
Pathophysiology of Ileus
The enteric nervous system is responsible for local regulation of the gastrointestinal system and is modulated by the central nervous system. Acetylcholine, neurokinin A, and substance P are stimulatory gastrointestinal neurotransmitters, whereas vasoactive intestinal peptide and nitrous oxide are inhibitory to gastrointestinal motility. Extrinsically, the sympathetic nervous input has an inhibitory effect on gastrointestinal motility, whereas parasympathetic input increases motility. 16 Suppression of parasympathetic activity and hyperactivity of the sympathetic nervous system in the postoperative period as a result of pain may be contributory. 25 Electrolyte abnormalities associated with blood loss, interstitial fluid shifts between compartments, and resuscitation postoperatively are also associated with ileus. 26 Opioid receptors play important roles in neurohormonal regulation throughout the central and enteric nervous systems. Opioid pain medication activates m-receptors in the bowel and contributes to decreased gastrointestinal motility. The cumulative dose of opioid medication has been shown to be an independent variable for ileus; 27 this suggests that a multimodal approach to pain management involving non-narcotic medications and selective regional anesthesia should be used whenever possible. 28 
Diagnosis
The term postoperative ileus should not be used as a catch-all phrase for cessation of bowel function after surgery. It is important to distinguish this diagnosis from other causes of decreased gastrointestinal function, such as mechanical obstruction of the large or small bowel. A careful history and physical examination is the first step in assessing for paralytic ileus.
Ileus may present with typical findings of abdominal distention, pain, bloating, nausea, emesis, and constipation. Patients may also experience significant eructation (ie, belching) and feelings of gastric reflux or heartburn. Patients should be asked about the return of bowel function, either via production of flatus or bowel movements in the postoperative period; patients with ileus will have minimal flatus and a lack of bowel movements.
Physical examination begins with exposing the entire abdomen. The appearance of the abdomen should be noted because it is typically distended in the case of ileus. The distended abdomen may be tympanic on percussion. Discrete tenderness of the abdomen, in conjunction with leukocytosis and elevated inflammatory markers, is not typical in a case of ileus and may be a red flag for true mechanical obstruction or other inflammatory process (eg, appendicitis, colitis, diverticulitis). Auscultation with a stethoscope typically yields no bowel sounds. This finding is in direct contrast to Ogilvie syndrome in which bowel sounds are often preserved as a result of continued small bowel function. A firm, acutely tender abdomen and/or a guarding response are indications that bowel perforation may have occurred; if detected, urgent supine and upright abdominal radiography and general surgical consultation are mandatory.
If ileus is suspected, a plain abdominal radiograph is a simple and effective screening tool (Figure 1 ). Distended loops of small and large bowel will be seen in a paralytic ileus (Figure 2 ), but these findings may be difficult to differentiate from a mechanical cause of obstruction. Ogilvie syndrome has dilated loops of large bowel with normal-appearing small bowel (Figure 3) . A contrast enema was historically used to diagnose a large bowel obstruction, but this technique has largely been replaced with CT. CT scans, with or without oral contrast, offer the advantage of being able to look for other potential causes of mechanical obstruction, colon wall thinning, and contained perforation, as well as being able to visualize the adjacent paracolic structures 16 (Figure 4 ).
Prevention/Prophylaxis
Chewing gum is a type of sham feeding that promotes intestinal motility through cephalic-vagal stimulation. In normal volunteers, chewing gum is as effective as food in stimulating cephalic-phase gastric secretion. 29, 30 In meta-analyses devoted to determining whether chewing gum should be part of a perioperative protocol to reduce ileus in patients undergoing abdominal surgery, results confirmed that chewing gum has some beneficial effect. [29] [30] [31] Virtually all studies evaluating the use of chewing gum to combat ileus have been in patients undergoing bowel resection or other intra-abdominal procedures, and the results may or may not be extrapolated to the orthopaedic population. Although patients who began chewing gum the morning after intestinal surgery had return of flatus and bowel movements earlier than did patients who did not chew gum, 29 chewing gum may not lead to differences in length of stay. 31 Although these analyses are based on small trials, chewing gum may actually be a cost-effective intervention that can be considered for selected patients. 30 
Treatment After Diagnosis
Traditional treatment of an uncomplicated ileus can be initiated once the diagnosis is made. Initially, the patient should be made nil per os. Significant accumulation of gastric and bowel secretions can lead to nausea and emesis. Dehydration may occur as a result of secretion retention within the gastrointestinal tract; treatment should consist of appropriate intravenous fluid resuscitation. Although routine use of nasogastric decompression is not warranted for every patient with ileus, selective use of nasogastric tubes in intractably nauseated patients or in patients at a high risk of aspiration should be a consideration.
Electrolyte abnormalities (ie, sodium, potassium, chloride, calcium, magnesium) should be assessed and corrected when ileus is diagnosed. Hyponatremia, hypokalemia, and hypocalcemia have all been seen in association with ileus and are thought to contribute to gastrointestinal dysfunction.
Early ambulation has been postulated to have a prokinetic effect on the gastrointestinal system, although the mechanism of ambulation on ileus resolution is unclear, and direct evidence of its utility is lacking. 32 Early ambulation in orthopaedic patients has known benefits, including the prevention of venous thromboembolic disease and respiratory infections postoperatively. Early ambulation is a simple, inexpensive investment of resources after orthopaedic surgery, and it should be included as part of a comprehensive early rehabilitation protocol whenever permissible. Algorithm demonstrating a strategy for evaluation of suspected ileus. NPO = nothing by mouth, WBC = white blood cell count.
Pharmacologic Interventions
Prokinetic motility drugs are commonly used following abdominal surgery to prevent ileus, although a Cochrane review 33 published in 2008 examined 39 randomized controlled trials and found most medications to be of little or no benefit. Erythromycin used as an early treatment for the prevention of ileus demonstrated no clinical effect in all trials included in this review. Alvimopan, a m-opioid antagonist that was still in an investigational stage, was the only medication whose use was supported. 33 Antiemetics can be used to help alleviate nausea associated with ileus. Metoclopramide has both antiemetic and prokinetic effects. It increases gastric emptying and, to a lesser extent, increases esophageal and small bowel motility. It exerts minimal effects on the distal small bowel and the colon. However, metoclopramide does not decrease the length of ileus, and it can lead to agitation or dystonic reactions in up to 20% of patients. 34 Pantothenic acid, also known as vitamin B 5 , has been proposed as a treatment of ileus. In a randomized study of orthopaedic patients, 35 the administration of dexpanthenol (ie, an alcohol derivative of pantothenic acid) significantly decreased the time from surgery to the first bowel movement. The study also showed a dose-response relationship between pantothenic acid and the decreasing time from surgery to the first bowel movement. 35 Neostigmine is an acetylcholinesterase inhibitor that increases cholinergic (ie, parasympathetic) activity within the gastrointestinal tract, leading to increased gastrointestinal motility. In a randomized trial, 36 patients with Ogilvie syndrome were randomly assigned to receive either 2 mg of neostigmine or saline; 10 of 11 patients in the treatment group had resolution of pseudo-obstruction at an average of 4 minutes. Treatment adverse effects were abdominal cramping, moderate to severe abdominal pain, excessive salivation, and emesis. Two patients in the study group were treated with atropine following the development of symptomatic bradycardia. 36 In seven patients who underwent orthopaedic spine surgery (ie, posterior lumbar fusion, anteroposterior lumbar fusion, lumbar laminectomy, Harrington rod stabilization of scoliosis), and who also received 2 mg of neostigmine, six of seven patients had prompt return of bowel function at an average of 5.25 minutes. This study excluded patients with a history of bradycardia or bronchospasm. 18 Prior to the administration of neostigmine, mechanical bowel obstruction, perforation, and bowel ischemia must be ruled out.
m-Opioid receptors (along with k and D receptors) are important mediators of the effects of opioids. The m-receptor is important in normal gastrointestinal function; its activation decreases gut motility. Not surprisingly, m receptors in the enteric nervous system are an attractive target for intervention; methylnaltrexone is one such selective m-receptor antagonist. It does not cross the blood-brain barrier; thus, it does not interfere with opioid pain medication. It has a short half-life of 2 to 3 hours and is administered intravenously or subcutaneously every 6 hours. Methylnaltrexone has been studied in opioid-induced constipation and was found more effective than placebo at producing a bowel movement at doses of 0.15 mg/kg and 0.3 mg/kg. 26 Methylnaltrexone has also been used successfully in the treatment of Ogilvie syndrome. 37 Alvimopan is another m-receptor antagonist, specific for gastrointestinal receptors, and it has a higher receptor affinity than methylnaltrexone. It is approved for use for the treatment of ileus in patients undergoing a bowel resection, and it has been used for the prevention of postoperative ileus in patients who have undergone bowel resection. 38, 39 Although its popularity has not yet spread beyond patients undergoing abdominal surgery, there may be clinical applicability in highrisk orthopaedic patients. The half-life of alvimopan is 2.5 to 6 hours, and it is administered orally twice daily. The dose for preventing postoperative ileus is 12 mg twice daily until the first flatus. 39 In a randomized trial of patients with opioid-induced bowel dysfunction, 54% of patients receiving a low dose of 1 mg daily had a bowel movement within 8 hours of administration compared with 43% of patients receiving 0.5 mg daily, and with 29% of patients receiving a placebo. Alvimopan did not antagonize opioid pain medication effects. 40 A similar study of patients receiving opioids also showed more spontaneous bowel movements in patients randomized to alvimopan, without requiring an increased narcotic dose. 41 
Surgical Treatment of Ileus
Surgery is not indicated in a true paralytic ileus in the absence of bowel perforation or ischemia. In general, surgical consultation early in the course of ileus is important to rule out more dangerous causes of cessation of bowel function. Ogilvie syndrome may lead to ischemic changes within the colon, perforation, sepsis, and even death; thus, whenever a diagnosis of Ogilvie syndrome is suspected because of cecal dilation observed on radiographic imaging, immediate surgical consultation is indicated. A, Abdominal CT scan with contrast demonstrating diffuse distention of the large and small bowel with no apparent transition zone in a patient with paralytic ileus. B, Abdominal CT scan demonstrating dilated loops of small bowel (white arrow), a transition zone, and collapsed small bowel loops (red arrow) in a patient with mechanical small bowel obstruction.
Historically, it was thought that colonic decompression via colonoscopy was indicated in select patients with Ogilvie syndrome. Recurrence of dilation after endoscopic decompression approaches 40%. 42 Surgery is associated with a high mortality rate; thus, it should be considered as a measure of final resort and in cases of bowel perforation. Colectomy should be reserved for patients who have sustained a perforation, who are at risk for such an event, or who have ischemic changes in the colon.
Summary
Though typically self-limiting, ileus may have substantial implications in terms of delayed patient mobilization, discomfort in the perioperative period, malnutrition, prolonged hospital stay, hospital readmission, and death in rare cases. In the current age of healthcare spending in which length of stay and hospital costs are being closely monitored, preventing and treating ileus are important factors in optimizing patient outcomes. Use of regional anesthesia when possible, early postoperative mobilization, prompt recognition of ileus, correct diagnosis, and early treatment interventions are important to achieving optimal outcomes.
